Ivanova et al., 2017 - Google Patents
The Content Analysis of ALDH^ sup+^ and SORE6^ sup+^ Populations of Cells in Cellular Lines of Thriple Negative Breast CancerIvanova et al., 2017
- Document ID
- 2034927812126714470
- Author
- Ivanova A
- Kravchenko D
- Lezhnin Y
- Chumakov S
- Frolova E
- Publication year
- Publication venue
- Journal of Pharmaceutical Sciences and Research
External Links
Snippet
Keywords: cancer stem cells, thriple negative breast cancer, glioblastoma, aldehyde dehydrogenase, reporter of SORE6. In neuronal and haematopoietic stem cells ALDH1 transfers retinal to retinoic acid, which through activation of its own nuclear receptors, serves …
- 230000001413 cellular 0 title abstract description 27
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gossett et al. | Hydrodynamic stretching of single cells for large population mechanical phenotyping | |
Posadas et al. | FYN is overexpressed in human prostate cancer | |
Vermeulen et al. | Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity | |
Duru et al. | HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells | |
Zantek et al. | MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer | |
Sonnenblick et al. | Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis | |
CN102812130A (en) | Recurrent Gene Fusions In Prostate Cancer | |
Yamamoto et al. | Metastasis from the tumor interior and necrotic core formation are regulated by breast cancer-derived angiopoietin-like 7 | |
Carlsson et al. | Paired high-content analysis of prostate cancer cells in bone marrow and blood characterizes increased androgen receptor expression in tumor cell clusters | |
Li et al. | Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis | |
Bagatur et al. | Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma | |
EP2823035A1 (en) | Adhesion signatures | |
Li et al. | Expression and clinical implication of S100A12 in gastric carcinoma | |
Felipe-Abrio et al. | Loss of MYBBP1A induces cancer stem cell activity in renal cancer | |
Lee et al. | Activated PyK2 and its Associated molecules Transduce Cellular Signaling from the cancerous milieu for Cancer Metastasis | |
Lamarca et al. | Urine telomerase for diagnosis and surveillance of bladder cancer | |
CN103698536A (en) | Oncoprotein P185 detection kit | |
Kaur et al. | Complex tumor spheroids, a tissue-mimicking tumor model, for drug discovery and precision medicine | |
Li et al. | Telomerase activity in preleukemia and acute myelogenous leukemia | |
Kim et al. | Expression of spermine oxidase is associated with colorectal carcinogenesis and prognosis of patients | |
Roelofs et al. | Aberrant apobec3b expression in breast cancer is linked to proliferation and cell cycle phase | |
Eturi et al. | Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma | |
Ivanova et al. | The Content Analysis of ALDH^ sup+^ and SORE6^ sup+^ Populations of Cells in Cellular Lines of Thriple Negative Breast Cancer | |
McKeever et al. | Patterns of antigenic expression of human glioma cells. | |
CN102053150B (en) | Human osteosarcoma stem cell related antigen marker and application thereof |